Need for Speed: From Human SARS-CoV-2 Samples to Protective and Efficacious Antibodies in Weeks.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 32649880.
- Also identified by DOI 10.1016/j.cell.2020.06.017 and PMC identifier 7346785.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The emergence of SARS-CoV-2 has driven a global research effort to identify medical countermeasures at an unprecedented pace. In this issue of Cell, Cao et al. identify thousands of SARS-CoV-2 neutralizing antibodies from convalescent donors. The authors improve our understanding of immunity against the coronavirus spike glycoprotein and detail novel pathways to rapidly identify and characterize protective monoclonal antibodies.
Medical subject headings
- Coronavirus Infections
- Pandemics
- Pneumonia, Viral
- Severe acute respiratory syndrome-related coronavirus